index,hot,title,href
1,,盛冠达股票量化2号私募基金11月小结,http://xueqiu.com/2657407918/269649021
2,,美团系列文章：短期边际展望与风险前瞻,http://xueqiu.com/9491872635/269610850
3,,“物以稀为贵”的橱窗基金——鹏华丰禄债券深度测评,http://xueqiu.com/2443086428/269497010
4,,论200625长安B的长期投资价值,http://xueqiu.com/1005499288/269409032
5,,泛东南亚的科技与狠活,http://xueqiu.com/9598793634/269389627
6,,拼多多的崛起不是因为消费降级,http://xueqiu.com/1156957441/269481163
7,,院内开花院外香——心脑血管中成药零售市场调研分享,http://xueqiu.com/1530955281/269356783
8,,投资猪周期会面临哪些风险？,http://xueqiu.com/3314653876/269459731
9,,经济演化中的收益递增,http://xueqiu.com/9927088462/269457388
10,,白酒投资札记：浓香、酱香、清香之争,http://xueqiu.com/1062170191/269439617
11,,港股到了性价比极高的区域——调研汇添富基金经理乐无穹,http://xueqiu.com/3891889332/269438577
12,,药明生物带崩生物医药，是错杀还是宣告CXO的寒冬？,http://xueqiu.com/1784228056/269403951
13,,雪球基金评审团招募！7只橱窗基金邀你来测评,http://xueqiu.com/8152922548/269407955
14,,微盘策略的第一轮认知周期,http://xueqiu.com/5278830487/269062842
15,,澄清北交所转板4个误解,http://xueqiu.com/9536074820/269304175
16,,2023年建仓药明康德注意事项,http://xueqiu.com/4473290236/269340118
17,,只考虑股息率的投资方法，可能是一种单相思,http://xueqiu.com/8548831484/269363751
18,,由“股王”破发引发的投资思考,http://xueqiu.com/6572050310/269364058
19,,行业探讨｜FEOC细则到底影响如何？,http://xueqiu.com/3199838879/269341532
20,,有点儿意思的血制品行业,http://xueqiu.com/6469147986/269339890
